![Bio-Rad Opens European headquarters in Basel, Switzerland, in April 2017 - Basel Area Business & Innovation Bio-Rad Opens European headquarters in Basel, Switzerland, in April 2017 - Basel Area Business & Innovation](https://baselarea.swiss//wp-content/uploads/2017/04/BioRad_Logo-1024x273-2.jpg)
Bio-Rad Opens European headquarters in Basel, Switzerland, in April 2017 - Basel Area Business & Innovation
![Bio-Rad: A Very Interesting Short-Term Investment Thanks To Gains On Sartorius Holding (NYSE:BIO) | Seeking Alpha Bio-Rad: A Very Interesting Short-Term Investment Thanks To Gains On Sartorius Holding (NYSE:BIO) | Seeking Alpha](https://static.seekingalpha.com/uploads/2020/5/29/49171940-15907397470124712_origin.jpg)
Bio-Rad: A Very Interesting Short-Term Investment Thanks To Gains On Sartorius Holding (NYSE:BIO) | Seeking Alpha
![Bio-Rad's SARS-CoV-2 (COVID-19) Serology Test Granted FDA Emergency Use Authorization, the First Total Antibody Test to Receive EUA from the FDA - BioTechniques Bio-Rad's SARS-CoV-2 (COVID-19) Serology Test Granted FDA Emergency Use Authorization, the First Total Antibody Test to Receive EUA from the FDA - BioTechniques](https://www.biotechniques.com/wp-content/uploads/2020/05/Bi-Rad_Platelia-SARS-CoV-2-Total-Ab-Assay-580x580.jpg)
Bio-Rad's SARS-CoV-2 (COVID-19) Serology Test Granted FDA Emergency Use Authorization, the First Total Antibody Test to Receive EUA from the FDA - BioTechniques
![Diamet SIA | Bio-Rad VIROTROL and VIROCLEAR Serological Controls for COVID-19 Clinical Assay Testing Diamet SIA | Bio-Rad VIROTROL and VIROCLEAR Serological Controls for COVID-19 Clinical Assay Testing](http://www.diamet.lv/images/ID-HERO-after.png)
Diamet SIA | Bio-Rad VIROTROL and VIROCLEAR Serological Controls for COVID-19 Clinical Assay Testing
![The Clinical Diagnostics division from Everlife-Chemopharm Group received two awards from Bio-Rad Southeast Asia 2023 | Articles, Event, News, Press Release, Publication | Chemopharm Group The Clinical Diagnostics division from Everlife-Chemopharm Group received two awards from Bio-Rad Southeast Asia 2023 | Articles, Event, News, Press Release, Publication | Chemopharm Group](https://www.chemopharm.com/wp-content/uploads/2023/03/combine001_jpeg.jpg)
The Clinical Diagnostics division from Everlife-Chemopharm Group received two awards from Bio-Rad Southeast Asia 2023 | Articles, Event, News, Press Release, Publication | Chemopharm Group
![The Clinical Diagnostics division from Everlife-Chemopharm Group received two awards from Bio-Rad Southeast Asia 2023 | Articles, Event, News, Press Release, Publication | Chemopharm Group The Clinical Diagnostics division from Everlife-Chemopharm Group received two awards from Bio-Rad Southeast Asia 2023 | Articles, Event, News, Press Release, Publication | Chemopharm Group](https://www.chemopharm.com/wp-content/uploads/2023/03/BioRad_Award_24Feb2023001.jpg)
The Clinical Diagnostics division from Everlife-Chemopharm Group received two awards from Bio-Rad Southeast Asia 2023 | Articles, Event, News, Press Release, Publication | Chemopharm Group
![Bio-Rad Enables Laboratory Excellence in Immunohematology with Launch of IH-500 NEXT Fully Automated System for ID-Cards - Clinical Laboratory int. Bio-Rad Enables Laboratory Excellence in Immunohematology with Launch of IH-500 NEXT Fully Automated System for ID-Cards - Clinical Laboratory int.](https://clinlabint.com/wp-content/uploads/sites/2/2023/05/IH-500-NEXT-picture.jpg)
Bio-Rad Enables Laboratory Excellence in Immunohematology with Launch of IH-500 NEXT Fully Automated System for ID-Cards - Clinical Laboratory int.
![Bio-Rad Expands Range of Quality Controls for Abbott Clinical Diagnostics Platforms - Clinical Laboratory int. Bio-Rad Expands Range of Quality Controls for Abbott Clinical Diagnostics Platforms - Clinical Laboratory int.](https://clinlabint.com/wp-content/uploads/sites/2/2022/12/image001.jpg)